Co-mutation - Globe Thesis

Keyword [Co-mutation] Result: 1 - 20 \| Page: 1 of 2
1.	Dissecting Cancer Genes And Their Functional Cooperation Based On Gene Functional Modules
2.	Clinical Analysis Of AML With NPM1 Gene Mutation
3.	Effect Of TP53 And EGFR Gene Co-mutation On The Efficacy Of EGFR-TKIs In Patients With Advanced Lung Adenocarcinoma
4.	Colony Analysis Of An ET Patient With JAK2 Exon12 And CALR Gene Co-mutation And Functional Research On The New Noncanonical Mutation Of JAK2 Exon12
5.	Clinical Features And Prognostic Analysis Of Adult Acute Myeloid Leukemia With FLT3-ITD And CEBPA Gene Co-mutation
6.	Analysis Of Genes And The Significance Of JAK3 Mutation In Adult Acute Lymphoblastic Leukemia
7.	Detection Of Multi-driver Gene And TP53 Gene In Peripheral Blood Of Patients With Advanced Non-small Cell Lung Cancer And Prognostic Effects Of Gene Co-mutation
8.	Clinical Characteristics And Prognosis Of Patients With Advanced Lung Adenocarcinoma With Co-mutation Of TP53/EGFR Gene
9.	The Exploratory Research Of NSCLC With Concomitant EGFR Mutations And ALK Rearrangements
10.	Correlation Between EGFR Co-mutation Type And EGFR-TKI Efficacy In Patients With NSCLC Study
11.	Non-interventional Observational Study Of EGFR Co-mutation In Patients With Advanced NSCLC In The Real World
12.	Clinical Application Analysis Of NGS Detection In 127 Cases Of Non-small Cell Lung Cancer
13.	Potential Predictive Value Of TP53 And ARID1A Co-mutation To Immune Checkpoint Inhibitors Therapy In Gastric Cancer
14.	Clinical Characteristics And Prognostic Significance Of BCOR/BCORL1 Gene Mutation In Patients With Myelodysplastic Syndromes
15.	1. The Role Of CD19 Epitope Deletion In BiTE Therapy For Immune Escape. 2. The Role Of The Combined Effect Of NPM1 Mutation And IDH1 Mutation In The Development Of AML
16.	Exploratory Study Of Potential Predictive Biomarkers In Gastrointestinal Cancer Treated With Molecular Targeted Therapy And Immune Checkpoint Inhibitors
17.	1.Multi-omics Analysis Unravels The Underlying Mechanisms Of Poor Prognosis And Differential Therapeutic Responses Of Solid Predominant Lung Adenocarcinoma 2.Study On The Heterogeneity Of Tumor Immune Microenvironment In Different Co-mutation Subtypes Of
18.	Efficacy And Safety Analyses Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Combined With Chemotherapy In Advanced Non–small-cell Lung Cancer With An EGFR/TP53 Co-mutation
19.	Relationship Between Positive Driving Gene And Clinical Characteristics In Non-small Cell Lung Cancer
20.	Analysis Of The Impact Of EGFR Co-mutations On The Efficacy Of Immune Checkpoint Inhibitors And Immune-Related Features In Advanced Non-small Cell Lung Cancer
<<First <Prev Next> Last>> Jump to